Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.

Francisco AcevedoBenjamín WalbaumMauricio CamusManuel ManzorSabrina MuñizLidia MedinaMilitza PetricPaula ReyesFrancisco DomínguezKlaus PuschelTomas MerinoM Loreto BravoMauricio P PintoCarolina IbáñezKevin HughesCesar Sanchez

Published in: Breast cancer research and treatment (2023)

In our cohort, 15% of BC patients who met NCCN criteria for germline testing were effectively tested. This percentage was even lower at the PH. Current recommendations encourage universal genetic testing for BC patients; however, our findings suggest that Chile is far from reaching such a goal and national guidelines in this regard are urgently needed. To our knowledge, this is the first study of its kind in Chile and Latin America.

Keyphrases

end stage renal disease
ejection fraction
clinical practice
newly diagnosed
healthcare
prognostic factors
peritoneal dialysis
oxidative stress
dna damage
patient reported